Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands
暂无分享,去创建一个
[1] J. Yewdell,et al. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.
[2] J. Vázquez,et al. A post‐translational modification of nuclear proteins, NG,NG‐dimethyl‐Arg, found in a natural HLA class I peptide ligand , 2000, Protein science : a publication of the Protein Society.
[3] T. Elliott,et al. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. , 1999, Journal of immunology.
[4] Daniel C Liebler,et al. Quantitative analysis of modified proteins by LC-MS/MS of peptides labeled with phenyl isocyanate. , 2003, Journal of proteome research.
[5] Mark D'Ascenzo,et al. 8‐Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease , 2007, Proteomics.
[6] D M Desiderio,et al. Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. , 1983, Biomedical mass spectrometry.
[7] J. Martinko,et al. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition. , 1993, Journal of immunology.
[8] O. Jensen,et al. Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry. , 2008, Journal of proteomics.
[9] Hans-Georg Rammensee,et al. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. , 2002, Cancer research.
[10] J. Sidney,et al. Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. , 2010, Human immunology.
[11] A. Nouri,et al. Comparative Study between Direct Mild Acid Extraction and Immunobead Purification Technique for Isolation of HLA Class I-Associated Peptides , 2002, Urologia Internationalis.
[12] J. Trowsdale,et al. Dynamics of proteasome distribution in living cells , 1997, The EMBO journal.
[13] J. Neefjes,et al. Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.
[14] B. J. Van den Eynde,et al. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. , 2001, Current opinion in immunology.
[15] M. Feltkamp,et al. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.
[16] Nina Hillen,et al. Features of TAP‐independent MHC class I ligands revealed by quantitative mass spectrometry , 2008, European journal of immunology.
[17] K. Parker,et al. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. , 1993, Journal of immunology.
[18] H. Rammensee,et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation , 1995, The Journal of experimental medicine.
[19] A Sette,et al. The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.
[20] M. Oldstone,et al. Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes* , 1999, The Journal of Biological Chemistry.
[21] V Brusic,et al. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. , 1998, Journal of immunology.
[22] Hans-Georg Rammensee,et al. Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.
[23] Lawrence Steinman,et al. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.
[24] A. Verkman,et al. Evidence for phosphorylation of serine 753 in CFTR using a novel metal‐ion affinity resin and matrix‐assisted laser desorption mass spectrometry , 1997, Protein science : a publication of the Protein Society.
[25] V. Engelhard,et al. Post-translational modifications of naturally processed MHC-binding epitopes. , 2006, Current opinion in immunology.
[26] Jacques Neefjes,et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. , 2004, Immunity.
[27] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[28] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[29] R. Aebersold,et al. Mass spectrometry in proteomics. , 2001, Chemical reviews.
[30] Jonathan W. Yewdell,et al. Immune recognition of a human renal cancer antigen through post-translational protein splicing , 2004, Nature.
[31] Hans-Georg Rammensee,et al. MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.
[32] Hans-Georg Rammensee,et al. Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface*S , 2007, Molecular & Cellular Proteomics.
[33] R. Henderson,et al. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.
[34] Forest M. White,et al. Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo , 2000, The Journal of experimental medicine.
[35] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[36] O. Johnell,et al. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans , 2005, European journal of immunology.
[37] Hans-Georg Rammensee,et al. MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.
[38] P. Edman,et al. A method for the determination of amino acid sequence in peptides. , 1949, Archives of biochemistry.
[39] P. Cresswell,et al. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. , 2002, Immunity.
[40] H. Rammensee,et al. Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling , 2004, Nature Biotechnology.
[41] Mark Lindsey,et al. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501 , 1997, Immunogenetics.
[42] P. Cresswell,et al. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer , 2007, Nature Immunology.
[43] E. Caron,et al. The MHC class I peptide repertoire is molded by the transcriptome , 2008, The Journal of experimental medicine.
[44] S. Stevanović,et al. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules. , 1999, Seminars in immunology.
[45] B. J. Van den Eynde,et al. Splicing of Distant Peptide Fragments Occurs in the Proteasome by Transpeptidation and Produces the Spliced Antigenic Peptide Derived from Fibroblast Growth Factor-5 , 2010, The Journal of Immunology.
[46] A. Goldberg,et al. Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.
[47] A. Purcell,et al. The use of post-source decay in matrix-assisted laser desorption/ionisation mass spectrometry to delineate T cell determinants. , 2001, Journal of immunological methods.
[48] D. Finley,et al. Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.
[49] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[50] P. Cresswell,et al. Tapasin and ERp57 form a stable disulfide‐linked dimer within the MHC class I peptide‐loading complex , 2005, The EMBO journal.
[51] S. Gendler,et al. Designer Glycopeptides for Cytotoxic T Cell–based Elimination of Carcinomas , 2004, The Journal of experimental medicine.
[52] L. Gardner,et al. Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans , 2009, Journal of Virology.
[53] Ilan Beer,et al. The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells* , 2006, Molecular & Cellular Proteomics.
[54] J. Neefjes,et al. Translocation of long peptides by transporters associated with antigen processing (TAP) , 1996, European journal of immunology.
[55] J. Coligan,et al. Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype. , 1985, Journal of immunology.
[56] F. Ginhoux,et al. Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport1 , 2003, The Journal of Immunology.
[57] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[58] S. Gygi,et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Shabanowitz,et al. Processing of a Class I-Restricted Epitope from Tyrosinase Requires Peptide N-Glycanase and the Cooperative Action of Endoplasmic Reticulum Aminopeptidase 1 and Cytosolic Proteases1 , 2006, The Journal of Immunology.
[60] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[61] Jeffrey K. Mito,et al. An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order , 2006, Science.
[62] Cécile Gouttefangeas,et al. Identification of tumor‐associated MHC class I ligands by a novel T cell‐independent approach , 2000, European journal of immunology.
[63] S. Nathenson,et al. Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.
[64] T. Elliott,et al. Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo , 1999, The Journal of experimental medicine.
[65] Nina Hillen,et al. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype , 2008, European journal of immunology.
[66] A. Agulnik,et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.
[67] A. Schmidt,et al. A novel strategy for quantitative proteomics using isotope‐coded protein labels , 2005, Proteomics.
[68] M. Münchbach,et al. Quantitation and facilitated de novo sequencing of proteins by isotopic N-terminal labeling of peptides with a fragmentation-directing moiety. , 2000, Analytical chemistry.
[69] M. Lotze,et al. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[70] Anne M Evans,et al. Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy , 2006, Proceedings of the National Academy of Sciences.
[71] Martin Gilar,et al. Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. , 2003, Analytical chemistry.
[72] K. Tanaka,et al. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.
[73] H. Rammensee,et al. Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. , 2009, Journal of proteome research.
[74] H. Rammensee,et al. Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.
[75] W Keilholz,et al. Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[76] Maria L. Wei,et al. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.
[77] V. Engelhard,et al. Tyrosinase degradation via two pathways during reverse translocation to the cytosol. , 2001, Biochemical and biophysical research communications.
[78] D. Kwiatkowski,et al. HLA class I typing by PCR: HLA-B27 and an African B27 subtype , 1991, The Lancet.
[79] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[80] A. Goldberg,et al. The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes , 1999, The Journal of Biological Chemistry.
[81] J. Bluestone,et al. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition , 1992, The Journal of experimental medicine.
[82] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[83] J. Shabanowitz,et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.
[84] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[85] Akira Hattori,et al. An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides , 2002, Nature Immunology.
[86] Andrew Emili,et al. De novo peptide sequencing and quantitative profiling of complex protein mixtures using mass-coded abundance tagging , 2002, Nature Biotechnology.
[87] A. S. Juncker,et al. Systematic Characterisation of Cellular Localisation and Expression Profiles of Proteins Containing MHC Ligands , 2009, PloS one.
[88] D. Heckerman,et al. Adaptive Interactions between HLA and HIV-1: Highly Divergent Selection Imposed by HLA Class I Molecules with Common Supertype Motifs , 2010, The Journal of Immunology.
[89] R. Vierkant,et al. HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. , 2009, Vaccine.
[90] J. Shabanowitz,et al. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for presentation of transformed self , 2008, Nature Immunology.
[91] B. Gückel,et al. A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. , 2001, Cancer research.
[92] S. Gygi,et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.
[93] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[94] H. Rammensee,et al. Peptides naturally presented by MHC class I molecules. , 1993, Annual review of immunology.
[95] T. Boon,et al. An Antigenic Peptide Produced by Peptide Splicing in the Proteasome , 2004, Science.
[96] Muthuraman Sathiamurthy,et al. Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire1 , 2004, The Journal of Immunology.
[97] M. Groettrup,et al. Proteasomes in immune cells: more than peptide producers? , 2010, Nature Reviews Immunology.
[98] N. Shastri,et al. The final touches make perfect the peptide-MHC class I repertoire. , 2007, Immunity.
[99] M. Bruening,et al. Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry. , 2009, Mass spectrometry reviews (Print).
[100] J. Yewdell,et al. The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.